{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:09:12Z","timestamp":1794532152421,"version":"4.9.1"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002860","name":"China Sponsorship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002860","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CGC.NL","award":["CGC.NL"],"award-info":[{"award-number":["CGC.NL"]}],"id":[{"id":"https:\/\/ror.org\/02y9qjz38","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To identify novel cancer therapies, the tumor microenvironment (TME) has received a lot of attention in recent years in particular with the advent of clinical successes achieved by targeting immune checkpoint inhibitors (ICIs). The TME consists of multiple cell types that are embedded in the extracellular matrix (ECM), including immune cells, endothelial cells and cancer associated fibroblasts (CAFs), which communicate with cancer cells and each other during tumor progression. CAFs are a dominant and heterogeneous cell type within the TME with a pivotal role in controlling cancer cell invasion and metastasis, immune evasion, angiogenesis and chemotherapy resistance. CAFs mediate their effects in part by remodeling the ECM and by secreting soluble factors and extracellular vesicles. Exosomes are a subtype of extracellular vesicles (EVs), which contain various biomolecules such as nucleic acids, lipids, and proteins. The biomolecules in exosomes can be transmitted from one to another cell, and thereby affect the behavior of the receiving cell. As exosomes are also present in circulation, their contents can also be explored as biomarkers for the diagnosis and prognosis of cancer patients. In this review, we concentrate on the role of CAFs-derived exosomes in the communication between CAFs and cancer cells and other cells of the TME. First, we introduce the multiple roles of CAFs in tumorigenesis. Thereafter, we discuss the ways CAFs communicate with cancer cells and interplay with other cells of the TME, and focus in particular on the role of exosomes. Then, we elaborate on the mechanisms by which CAFs-derived exosomes contribute to cancer progression, as well as and the clinical impact of exosomes. We conclude by discussing aspects of exosomes that deserve further investigation, including emerging insights into making treatment with immune checkpoint inhibitor blockade more efficient.<\/jats:p>","DOI":"10.1186\/s12943-021-01463-y","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T03:06:08Z","timestamp":1638327968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":333,"title":["Cancer associated-fibroblast-derived exosomes in cancer progression"],"prefix":"10.1186","volume":"20","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilson Fonseca","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-342X","authenticated-orcid":false,"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"5","key":"1463_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell."},{"key":"1463_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev.bi.60.070191.001433","volume":"60","author":"HR Herschman","year":"1991","unstructured":"Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281\u2013319.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"1463_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1055\/s-0039-1687908","volume":"45","author":"HF Dvorak","year":"2019","unstructured":"Dvorak HF. Tumors: Wounds That Do Not Heal-A Historical Perspective with a Focus on the Fundamental Roles of Increased Vascular Permeability and Clotting. Semin Thromb Hemost. 2019;45(6):576\u201392.","journal-title":"Semin Thromb Hemost"},{"issue":"26","key":"1463_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650\u20139.","journal-title":"N Engl J Med"},{"issue":"24","key":"1463_CR5","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1111\/febs.14586","volume":"285","author":"GM Sundaram","year":"2018","unstructured":"Sundaram GM, Quah S, Sampath P. Cancer: the dark side of wound healing. FEBS J. 2018;285(24):4516\u201334.","journal-title":"FEBS J"},{"issue":"1","key":"1463_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152729","volume":"216","author":"PI Ribeiro Franco","year":"2020","unstructured":"Ribeiro Franco PI, Rodrigues AP, de Menezes LB, Pacheco MM. Tumor microenvironment components: Allies of cancer progression. Pathol Res Pract. 2020;216(1):152729.","journal-title":"Pathol Res Pract"},{"key":"1463_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"key":"1463_CR8","doi-asserted-by":"crossref","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci. 2019;20(4):840.","DOI":"10.3390\/ijms20040840"},{"key":"1463_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","volume":"1060","author":"AE Denton","year":"2018","unstructured":"Denton AE, Roberts EW, Fearon DT. Stromal Cells in the Tumor Microenvironment. Adv Exp Med Biol. 2018;1060:99\u2013114.","journal-title":"Adv Exp Med Biol"},{"key":"1463_CR10","doi-asserted-by":"crossref","unstructured":"Blomberg OS, Spagnuolo L, de Visser KE. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Dis Model Mech. 2018;11(10):dmm036236.","DOI":"10.1242\/dmm.036236"},{"issue":"2","key":"1463_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","volume":"20","author":"P Sharma","year":"2020","unstructured":"Sharma P, Allison JP. Dissecting the mechanisms of immune checkpoint therapy. Nat Rev Immunol. 2020;20(2):75\u20136.","journal-title":"Nat Rev Immunol"},{"key":"1463_CR12","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3389\/fimmu.2020.01956","volume":"11","author":"Y Song","year":"2020","unstructured":"Song Y, Fu Y, Xie Q, Zhu B, Wang J, Zhang B. Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment. Front Immunol. 2020;11:1956.","journal-title":"Front Immunol"},{"key":"1463_CR13","doi-asserted-by":"crossref","unstructured":"Olejarz W, Kubiak-Tomaszewska G, Chrzanowska A, Lorenc T. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers. Int J Mol Sci. 2020;21(16):5840.","DOI":"10.3390\/ijms21165840"},{"issue":"9","key":"1463_CR14","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","volume":"52","author":"WS Lee","year":"2020","unstructured":"Lee WS, Yang H, Chon HJ, Kim C. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Exp Mol Med. 2020;52(9):1475\u201385.","journal-title":"Exp Mol Med"},{"key":"1463_CR15","doi-asserted-by":"crossref","unstructured":"LeBleu VS, Kalluri R. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech. 2018;11(4):dmm029447.","DOI":"10.1242\/dmm.029447"},{"key":"1463_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2018.00414","volume":"9","author":"L Ziani","year":"2018","unstructured":"Ziani L, Chouaib S, Thiery J. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts. Front Immunol. 2018;9:414.","journal-title":"Front Immunol"},{"issue":"8","key":"1463_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1084\/jem.20140692","volume":"211","author":"D Ohlund","year":"2014","unstructured":"Ohlund D, Elyada E, Tuveson D. Fibroblast heterogeneity in the cancer wound. J Exp Med. 2014;211(8):1503\u201323.","journal-title":"J Exp Med"},{"issue":"8","key":"1463_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","volume":"9","author":"M Erkan","year":"2012","unstructured":"Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9(8):454\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"8","key":"1463_CR19","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/cas.14537","volume":"111","author":"R Kanzaki","year":"2020","unstructured":"Kanzaki R, Pietras K. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine. Cancer Sci. 2020;111(8):2708\u201317.","journal-title":"Cancer Sci"},{"issue":"4","key":"1463_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/cas.14346","volume":"111","author":"Y Miyai","year":"2020","unstructured":"Miyai Y, Esaki N, Takahashi M, Enomoto A. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives. Cancer Sci. 2020;111(4):1047\u201357.","journal-title":"Cancer Sci"},{"key":"1463_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2021.08.002","volume":"520","author":"B Chandra Jena","year":"2021","unstructured":"Chandra Jena B, Sarkar S, Rout L, Mandal M. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-beta in CAF mediated tumor progression and therapeutic resistance. Cancer Lett. 2021;520:222\u201332.","journal-title":"Cancer Lett"},{"issue":"1","key":"1463_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol Rev. 2021;101(1):147\u201376.","journal-title":"Physiol Rev"},{"issue":"25","key":"1463_CR23","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41388-019-0765-y","volume":"38","author":"L Bu","year":"2019","unstructured":"Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, et al. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38(25):4887\u2013901.","journal-title":"Oncogene."},{"issue":"5","key":"1463_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2019;16(5):282\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1463_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: Cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146(4):895\u2013905.","journal-title":"Int J Cancer"},{"issue":"9","key":"1463_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.trecan.2020.03.007","volume":"6","author":"VS LeBleu","year":"2020","unstructured":"LeBleu VS, Kalluri R. Exosomes as a Multicomponent Biomarker Platform in Cancer. Trends Cancer. 2020;6(9):767\u201374.","journal-title":"Trends Cancer."},{"issue":"4","key":"1463_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020;182(4):1044\u201361.","journal-title":"Cell."},{"key":"1463_CR28","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells. 2019;8(4):307.","DOI":"10.3390\/cells8040307"},{"issue":"10","key":"1463_CR29","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1111\/cas.13735","volume":"109","author":"N Seo","year":"2018","unstructured":"Seo N, Akiyoshi K, Shiku H. Exosome-mediated regulation of tumor immunology. Cancer Sci. 2018;109(10):2998\u20133004.","journal-title":"Cancer Sci"},{"key":"1463_CR30","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3389\/fimmu.2020.01612","volume":"11","author":"MC Knox","year":"2020","unstructured":"Knox MC, Ni J, Bece A, Bucci J, Chin Y, Graham PH, et al. A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications. Front Immunol. 2020;11:1612.","journal-title":"Front Immunol"},{"issue":"6","key":"1463_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2020.02.013","volume":"6","author":"W Yan","year":"2020","unstructured":"Yan W, Jiang S. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle. Trends Cancer. 2020;6(6):506\u201317.","journal-title":"Trends Cancer"},{"key":"1463_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-319-74470-4_7","volume":"1056","author":"Y Huang","year":"2018","unstructured":"Huang Y, Liu K, Li Q, Yao Y, Wang Y. Exosomes Function in Tumor Immune Microenvironment. Adv Exp Med Biol. 2018;1056:109\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"1463_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00281-018-0689-6","volume":"40","author":"MW Graner","year":"2018","unstructured":"Graner MW, Schnell S, Olin MR. Tumor-derived exosomes, microRNAs, and cancer immune suppression. Semin Immunopathol. 2018;40(5):505\u201315.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1463_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2020","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2020;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1463_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"1463_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coi.2020.03.004","volume":"64","author":"R Barrett","year":"2020","unstructured":"Barrett R, Pure E. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy. Curr Opin Immunol. 2020;64:80\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1463_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18(1):70.","journal-title":"Mol Cancer"},{"issue":"1","key":"1463_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/cbf.1188","volume":"24","author":"HP Ehrlich","year":"2006","unstructured":"Ehrlich HP, Allison GM, Leggett M. The myofibroblast, cadherin, alpha smooth muscle actin and the collagen effect. Cell Biochem Funct. 2006;24(1):63\u201370.","journal-title":"Cell Biochem Funct"},{"issue":"20","key":"1463_CR39","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","volume":"79","author":"Y Mizutani","year":"2019","unstructured":"Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, et al. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis. Cancer Res. 2019;79(20):5367\u201381.","journal-title":"Cancer Res"},{"issue":"2","key":"1463_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cell.2020.03.013","volume":"181","author":"D Park","year":"2020","unstructured":"Park D, Sahai E, Rullan A. SnapShot: Cancer-Associated Fibroblasts. Cell. 2020;181(2):486.","journal-title":"Cell."},{"issue":"3","key":"1463_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D Ohlund","year":"2017","unstructured":"Ohlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"8","key":"1463_CR42","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov."},{"issue":"3","key":"1463_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. Cancer Cell. 2018;33(3):463\u201379.","journal-title":"Cancer Cell"},{"issue":"5","key":"1463_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49(5):708\u201318.","journal-title":"Nat Genet"},{"issue":"38","key":"1463_CR45","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci U S A. 2016;113(38):E5618\u201327.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1463_CR46","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, et al. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer. Cancer Discov. 2020;10(9):1330\u201351.","journal-title":"Cancer Discov."},{"issue":"1","key":"1463_CR47","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150.","journal-title":"Nat Commun"},{"issue":"2","key":"1463_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez CX, Muller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, et al. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy. Cancer Discov. 2020;10(2):232\u201353.","journal-title":"Cancer Discov"},{"issue":"3","key":"1463_CR49","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/anie.201506262","volume":"55","author":"T Ji","year":"2016","unstructured":"Ji T, Zhao Y, Ding Y, Wang J, Zhao R, Lang J, et al. Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation. Angew Chem Int Ed Engl. 2016;55(3):1050\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"1463_CR50","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/ijc.25612","volume":"128","author":"E Flaberg","year":"2011","unstructured":"Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer. 2011;128(12):2793\u2013802.","journal-title":"Int J Cancer"},{"issue":"14","key":"1463_CR51","first-page":"3379","volume":"59","author":"SJ Engle","year":"1999","unstructured":"Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor \u03b21 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 1999;59(14):3379\u201386.","journal-title":"Cancer Res"},{"issue":"6","key":"1463_CR52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334.","journal-title":"Cancer Cell"},{"issue":"7","key":"1463_CR53","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1078-0432.CCR-15-2851","volume":"23","author":"HM Brechbuhl","year":"2017","unstructured":"Brechbuhl HM, Finlay-Schultz J, Yamamoto TM, Gillen AE, Cittelly DM, Tan AC, et al. Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen. Clin Cancer Res. 2017;23(7):1710\u201321.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1463_CR54","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ijc.29804","volume":"138","author":"K Fanhchaksai","year":"2016","unstructured":"Fanhchaksai K, Okada F, Nagai N, Pothacharoen P, Kongtawelert P, Hatano S, et al. Host stromal versican is essential for cancer-associated fibroblast function to inhibit cancer growth. Int J Cancer. 2016;138(3):630\u201341.","journal-title":"Int J Cancer"},{"issue":"2","key":"1463_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"key":"1463_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ceb.2018.09.002","volume":"56","author":"J Barbazan","year":"2019","unstructured":"Barbazan J, Matic VD. Cancer associated fibroblasts: is the force the path to the dark side? Curr Opin Cell Biol. 2019;56:71\u20139.","journal-title":"Curr Opin Cell Biol"},{"issue":"11","key":"1463_CR57","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-018-1104-x","volume":"9","author":"L Wei","year":"2018","unstructured":"Wei L, Ye H, Li G, Lu Y, Zhou Q, Zheng S, et al. Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1\/SATB-1 pathway in pancreatic cancer. Cell Death Dis. 2018;9(11):1065.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1463_CR58","doi-asserted-by":"publisher","first-page":"921","DOI":"10.7150\/thno.22182","volume":"8","author":"X Qin","year":"2018","unstructured":"Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X, et al. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. Theranostics. 2018;8(4):921\u201340.","journal-title":"Theranostics."},{"key":"1463_CR59","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fimmu.2019.01394","volume":"10","author":"G Landskron","year":"2019","unstructured":"Landskron G, De la Fuente LM, Dubois-Camacho K, Diaz-Jimenez D, Orellana-Serradell O, Romero D, et al. Interleukin 33\/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer. Front Immunol. 2019;10:1394.","journal-title":"Front Immunol"},{"issue":"1","key":"1463_CR60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, et al. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Cell. 2019;178(1):160\u201375.","journal-title":"Cell."},{"issue":"42","key":"1463_CR61","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1038\/onc.2015.315","volume":"34","author":"S Kale","year":"2015","unstructured":"Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha9beta1 integrin. Oncogene. 2015;34(42):5408\u201310.","journal-title":"Oncogene."},{"issue":"1","key":"1463_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-018-0758-4","volume":"17","author":"Y Ren","year":"2018","unstructured":"Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, et al. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ss1 secretion. Mol Cancer. 2018;17(1):5.","journal-title":"Mol Cancer"},{"issue":"3","key":"1463_CR63","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/bjc.2013.768","volume":"110","author":"Y Yu","year":"2014","unstructured":"Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ, Feng YM. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer. 2014;110(3):724\u201332.","journal-title":"Br J Cancer"},{"issue":"24","key":"1463_CR64","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1158\/1078-0432.CCR-18-0329","volume":"24","author":"M Paauwe","year":"2018","unstructured":"Paauwe M, Schoonderwoerd MJA, Helderman R, Harryvan TJ, Groenewoud A, van Pelt GW, et al. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Clin Cancer Res. 2018;24(24):6331\u201344.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1463_CR65","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/15384047.2019.1685157","volume":"21","author":"HX Tan","year":"2020","unstructured":"Tan HX, Gong WZ, Zhou K, Xiao ZG, Hou FT, Huang T, et al. CXCR4\/TGF-beta1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer. Cancer Biol Ther. 2020;21(3):258\u201368.","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"1463_CR66","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77(9):1745\u201370.","journal-title":"Cell Mol Life Sci"},{"issue":"30","key":"1463_CR67","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.3748\/wjg.v22.i30.6841","volume":"22","author":"N Kubo","year":"2016","unstructured":"Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol. 2016;22(30):6841\u201350.","journal-title":"World J Gastroenterol"},{"key":"1463_CR68","doi-asserted-by":"crossref","unstructured":"Kugeratski FG, Atkinson SJ, Neilson LJ, Lilla S, Knight JRP, Serneels J, et al. Hypoxic cancer-associated fibroblasts increase NCBP2-AS2\/HIAR to promote endothelial sprouting through enhanced VEGF signaling. Sci Signal. 2019;12(567):eaan8247.","DOI":"10.1126\/scisignal.aan8247"},{"issue":"2","key":"1463_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","volume":"23","author":"D Unterleuthner","year":"2020","unstructured":"Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B, Nivarthi H, et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis. 2020;23(2):159\u201377.","journal-title":"Angiogenesis."},{"issue":"18","key":"1463_CR70","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.7150\/thno.26546","volume":"8","author":"Q Sun","year":"2018","unstructured":"Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, et al. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics. 2018;8(18):5072\u201387.","journal-title":"Theranostics."},{"issue":"3","key":"1463_CR71","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","volume":"9","author":"AJ Petty","year":"2017","unstructured":"Petty AJ, Yang Y. Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy. 2017;9(3):289\u2013302.","journal-title":"Immunotherapy."},{"key":"1463_CR72","doi-asserted-by":"crossref","unstructured":"Berzaghi R, Ahktar MA, Islam A, Pedersen BD, Hellevik T, Martinez-Zubiaurre I. Fibroblast-Mediated Immunoregulation of Macrophage Function Is Maintained after Irradiation. Cancers (Basel). 2019;11(5):689.","DOI":"10.3390\/cancers11050689"},{"issue":"2","key":"1463_CR73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/cam4.993","volume":"6","author":"A Zhang","year":"2017","unstructured":"Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, et al. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med. 2017;6(2):463\u201370.","journal-title":"Cancer Med."},{"issue":"19","key":"1463_CR74","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/onc.2013.191","volume":"33","author":"G Comito","year":"2014","unstructured":"Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014;33(19):2423\u201331.","journal-title":"Oncogene."},{"issue":"4","key":"1463_CR75","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2008.07.016","volume":"135","author":"IV Pinchuk","year":"2008","unstructured":"Pinchuk IV, Saada JI, Beswick EJ, Boya G, Qiu SM, Mifflin RC, et al. PD-1 ligand expression by human colonic myofibroblasts\/fibroblasts regulates CD4+ T-cell activity. Gastroenterology. 2008;135(4):1228\u201337.","journal-title":"Gastroenterology."},{"issue":"2","key":"1463_CR76","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","volume":"318","author":"T Li","year":"2012","unstructured":"Li T, Yang Y, Hua X, Wang G, Liu W, Jia C, et al. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer Lett. 2012;318(2):154\u201361.","journal-title":"Cancer Lett"},{"issue":"2","key":"1463_CR77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1871520616666161031143301","volume":"17","author":"L Schwartz","year":"2017","unstructured":"Schwartz L, Supuran CT, Alfarouk KO. The Warburg Effect and the Hallmarks of Cancer. Anti Cancer Agents Med Chem. 2017;17(2):164\u201370.","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"7","key":"1463_CR78","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139.","journal-title":"Int J Radiat Biol"},{"issue":"23","key":"1463_CR79","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8(23):3984\u20134001.","journal-title":"Cell Cycle"},{"key":"1463_CR80","doi-asserted-by":"crossref","unstructured":"Gentric G, Mechta-Grigoriou F. Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers (Basel). 2021;13(3):399.","DOI":"10.3390\/cancers13030399"},{"issue":"3","key":"1463_CR81","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","volume":"44","author":"L Wilde","year":"2017","unstructured":"Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, et al. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol. 2017;44(3):198\u2013203.","journal-title":"Semin Oncol"},{"issue":"4","key":"1463_CR82","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7150\/ijbs.10666","volume":"11","author":"XJ Shen","year":"2015","unstructured":"Shen XJ, Zhang H, Tang GS, Wang XD, Zheng R, Wang Y, et al. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Int J Biol Sci. 2015;11(4):370\u20139.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"1463_CR83","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/path.4034","volume":"227","author":"SA Simpkins","year":"2012","unstructured":"Simpkins SA, Hanby AM, Holliday DL, Speirs V. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol. 2012;227(4):490\u20138.","journal-title":"J Pathol"},{"key":"1463_CR84","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/ncomms16031","volume":"8","author":"O Olivares","year":"2017","unstructured":"Olivares O, Mayers JR, Gouirand V, Torrence ME, Gicquel T, Borge L, et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017;8:16031.","journal-title":"Nat Commun"},{"issue":"1","key":"1463_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","volume":"29","author":"M Curtis","year":"2019","unstructured":"Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, et al. Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019;29(1):141\u201355.","journal-title":"Cell Metab"},{"key":"1463_CR86","doi-asserted-by":"crossref","unstructured":"Sanford-Crane H, Abrego J, Sherman MH. Fibroblasts as Modulators of Local and Systemic Cancer Metabolism. Cancers (Basel). 2019;11(5):619.","DOI":"10.3390\/cancers11050619"},{"key":"1463_CR87","doi-asserted-by":"crossref","unstructured":"Dominiak A, Chelstowska B, Olejarz W, Nowicka G. Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions. Cancers (Basel). 2020;12(5):1232.","DOI":"10.3390\/cancers12051232"},{"key":"1463_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yjmcc.2016.03.005","volume":"94","author":"J Pellman","year":"2016","unstructured":"Pellman J, Zhang J, Sheikh F. Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems. J Mol Cell Cardiol. 2016;94:22\u201331.","journal-title":"J Mol Cell Cardiol"},{"key":"1463_CR89","doi-asserted-by":"crossref","unstructured":"Roehlecke C, Schmidt MHH. Tunneling Nanotubes and Tumor Microtubes in Cancer. Cancers (Basel). 2020;12(4):857.","DOI":"10.3390\/cancers12040857"},{"issue":"7238","key":"1463_CR90","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nature07869","volume":"458","author":"S Maeda","year":"2009","unstructured":"Maeda S, Nakagawa S, Suga M, Yamashita E, Oshima A, Fujiyoshi Y, et al. Structure of the connexin 26 gap junction channel at 3.5 A resolution. Nature. 2009;458(7238):597\u2013602.","journal-title":"Nature."},{"issue":"2","key":"1463_CR91","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1073\/pnas.022324499","volume":"99","author":"Y Qu","year":"2002","unstructured":"Qu Y, Dahl G. Function of the voltage gate of gap junction channels: selective exclusion of molecules. Proc Natl Acad Sci U S A. 2002;99(2):697\u2013702.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1463_CR92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000495232","volume":"51","author":"M Luo","year":"2018","unstructured":"Luo M, Luo Y, Mao N, Huang G, Teng C, Wang H, et al. Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication. Cell Physiol Biochem. 2018;51(1):315\u201336.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1463_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s004030050180","volume":"289","author":"A Trautmann","year":"1997","unstructured":"Trautmann A, Feuerstein B, Ernst N, Brocker EB, Klein CE. Heterotypic cell-cell adhesion of human mast cells to fibroblasts. Arch Dermatol Res. 1997;289(4):194\u2013203.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"1463_CR94","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1182\/blood.V79.3.650.650","volume":"79","author":"S Adachi","year":"1992","unstructured":"Adachi S, Ebi Y, Nishikawa S, Hayashi S, Yamazaki M, Kasugai T, et al. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood. 1992;79(3):650\u20136.","journal-title":"Blood."},{"issue":"10","key":"1463_CR95","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.4049\/jimmunol.160.10.5053","volume":"160","author":"A Trautmann","year":"1998","unstructured":"Trautmann A, Krohne G, Br\u00f6cker EB, Klein CE. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J Immunol. 1998;160(10):5053\u20137.","journal-title":"J Immunol"},{"issue":"11","key":"1463_CR96","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.tips.2014.09.006","volume":"35","author":"DB Wright","year":"2014","unstructured":"Wright DB, Meurs H, Dekkers BG. Integrins: therapeutic targets in airway hyperresponsiveness and remodelling? Trends Pharmacol Sci. 2014;35(11):567\u201374.","journal-title":"Trends Pharmacol Sci"},{"key":"1463_CR97","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yjmcc.2016.01.011","volume":"91","author":"I Valiente-Alandi","year":"2016","unstructured":"Valiente-Alandi I, Schafer AE, Blaxall BC. Extracellular matrix-mediated cellular communication in the heart. J Mol Cell Cardiol. 2016;91:228\u201337.","journal-title":"J Mol Cell Cardiol"},{"issue":"16","key":"1463_CR98","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1242\/dev.128.16.3117","volume":"128","author":"M Simian","year":"2001","unstructured":"Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development. 2001;128(16):3117\u201331.","journal-title":"Development."},{"issue":"5\u20136","key":"1463_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201700167","volume":"18","author":"A Santi","year":"2018","unstructured":"Santi A, Kugeratski FG, Zanivan S. Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. Proteomics. 2018;18(5\u20136):e1700167.","journal-title":"Proteomics."},{"key":"1463_CR100","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"HO Lee","year":"2011","unstructured":"Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. 2011;11:245.","journal-title":"BMC Cancer"},{"issue":"1","key":"1463_CR101","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","volume":"9","author":"A Kaur","year":"2019","unstructured":"Kaur A, Ecker BL, Douglass SM, Kugel CH 3rd, Webster MR, Almeida FV, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2019;9(1):64\u201381.","journal-title":"Cancer Discov."},{"key":"1463_CR102","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran L, Erez N. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment. Front Immunol. 2019;10:1835.","journal-title":"Front Immunol"},{"issue":"1","key":"1463_CR103","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","volume":"29","author":"T Bertero","year":"2019","unstructured":"Bertero T, Oldham WM, Grasset EM, Bourget I, Boulter E, Pisano S, et al. Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy. Cell Metab. 2019;29(1):124\u201340.","journal-title":"Cell Metab"},{"issue":"1","key":"1463_CR104","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","volume":"26","author":"T Valencia","year":"2014","unstructured":"Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell. 2014;26(1):121\u201335.","journal-title":"Cancer Cell"},{"issue":"7617","key":"1463_CR105","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536(7617):479\u201383.","journal-title":"Nature."},{"issue":"1","key":"1463_CR106","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles."},{"issue":"1","key":"1463_CR107","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-019-0973-7","volume":"18","author":"X Bian","year":"2019","unstructured":"Bian X, Xiao YT, Wu T, Yao M, Du L, Ren S, et al. Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression. Mol Cancer. 2019;18(1):50.","journal-title":"Mol Cancer"},{"key":"1463_CR108","doi-asserted-by":"crossref","unstructured":"Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J. The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int J Mol Sci. 2017;18(6):1153.","DOI":"10.3390\/ijms18061153"},{"key":"1463_CR109","doi-asserted-by":"crossref","unstructured":"Menck K, Sivaloganathan S, Bleckmann A, Binder C. Microvesicles in Cancer: Small Size, Large Potential. Int J Mol Sci. 2020;21(15):5373.","DOI":"10.3390\/ijms21155373"},{"key":"1463_CR110","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fonc.2019.00356","volume":"9","author":"X Yang","year":"2019","unstructured":"Yang X, Li Y, Zou L, Zhu Z. Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells. Front Oncol. 2019;9:356.","journal-title":"Front Oncol"},{"issue":"1","key":"1463_CR111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145.","journal-title":"Signal Transduct Target Ther"},{"key":"1463_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","volume":"188","author":"MP Bebelman","year":"2018","unstructured":"Bebelman MP, Smit MJ, Pegtel DM, Baglio SR. Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther. 2018;188:1\u201311.","journal-title":"Pharmacol Ther"},{"key":"1463_CR113","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.","DOI":"10.1126\/science.aau6977"},{"issue":"2","key":"1463_CR114","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75(2):193\u2013208.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1463_CR115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75.","journal-title":"Mol Cancer"},{"issue":"4","key":"1463_CR116","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/cr.2015.29","volume":"25","author":"B Roucourt","year":"2015","unstructured":"Roucourt B, Meeussen S, Bao J, Zimmermann P, David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 2015;25(4):412\u201328.","journal-title":"Cell Res"},{"issue":"7","key":"1463_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201700456","volume":"18","author":"S Staubach","year":"2018","unstructured":"Staubach S, Wenzel A, Beck BB, Rinschen MM, Muller S, Hanisch FG. Autosomal Tubulointerstitial Kidney Disease-MUC1 Type: Differential Proteomics Suggests that Mutated MUC1 (insC) Affects Vesicular Transport in Renal Epithelial Cells. Proteomics. 2018;18(7):e1700456.","journal-title":"Proteomics."},{"issue":"6","key":"1463_CR118","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/brain\/awaa110","volume":"143","author":"Z Yu","year":"2020","unstructured":"Yu Z, Shi M, Stewart T, Fernagut PO, Huang Y, Tian C, et al. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction. Brain. 2020;143(6):1780\u201397.","journal-title":"Brain."},{"issue":"1","key":"1463_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19\u201330.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1463_CR120","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","volume":"36","author":"ER Abels","year":"2016","unstructured":"Abels ER, Breakefield XO. Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake. Cell Mol Neurobiol. 2016;36(3):301\u201312.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"1463_CR121","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1541-7786.MCR-18-0891","volume":"17","author":"A Gonda","year":"2019","unstructured":"Gonda A, Kabagwira J, Senthil GN, Wall NR. Internalization of Exosomes through Receptor-Mediated Endocytosis. Mol Cancer Res. 2019;17(2):337\u201347.","journal-title":"Mol Cancer Res"},{"issue":"32","key":"1463_CR122","doi-asserted-by":"publisher","first-page":"22258","DOI":"10.1074\/jbc.M114.588046","volume":"289","author":"T Tian","year":"2014","unstructured":"Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258\u201367.","journal-title":"J Biol Chem"},{"key":"1463_CR123","doi-asserted-by":"crossref","unstructured":"Buratta S, Tancini B, Sagini K, Delo F, Chiaradia E, Urbanelli L, et al. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular. Int J Mol Sci. 2020;21(7):2576.","DOI":"10.3390\/ijms21072576"},{"issue":"4","key":"1463_CR124","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1463_CR125","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1463_CR126","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-017-0706-8","volume":"16","author":"W Li","year":"2017","unstructured":"Li W, Li C, Zhou T, Liu X, Liu X, Li X, et al. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017;16(1):145.","journal-title":"Mol Cancer"},{"issue":"1","key":"1463_CR127","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","volume":"10","author":"D von Ahrens","year":"2017","unstructured":"von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017;10(1):76.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1463_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","volume":"44","author":"G Shan","year":"2021","unstructured":"Shan G, Zhou X, Gu J, Zhou D, Cheng W, Wu H, et al. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/beta-catenin pathway and upregulating PTEN. Cell Oncol (Dordr). 2021;44(1):45\u201359.","journal-title":"Cell Oncol (Dordr)"},{"key":"1463_CR129","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.omtn.2019.11.024","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, Wei H, Wang J, Li L, Chen A, Li Z. MicroRNA-181d-5p-Containing Exosomes Derived from CAFs Promote EMT by Regulating CDX2\/HOXA5 in Breast Cancer. Mol Ther Nucleic Acids. 2020;19:654\u201367.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"1463_CR130","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s12010-020-03244-7","volume":"191","author":"Y Li","year":"2020","unstructured":"Li Y, Zhao Z, Liu W, Li X. SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming. Appl Biochem Biotechnol. 2020;191(3):1084\u201399.","journal-title":"Appl Biochem Biotechnol"},{"issue":"12","key":"1463_CR131","doi-asserted-by":"publisher","first-page":"19592","DOI":"10.18632\/oncotarget.14752","volume":"8","author":"E Donnarumma","year":"2017","unstructured":"Donnarumma E, Fiore D, Nappa M, Roscigno G, Adamo A, Iaboni M, et al. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget. 2017;8(12):19592\u2013608.","journal-title":"Oncotarget."},{"issue":"9","key":"1463_CR132","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ncb3021","volume":"16","author":"M Shimoda","year":"2014","unstructured":"Shimoda M, Principe S, Jackson HW, Luga V, Fang H, Molyneux SD, et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat Cell Biol. 2014;16(9):889\u2013901.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"1463_CR133","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932\u201347.","journal-title":"Theranostics."},{"issue":"21","key":"1463_CR134","doi-asserted-by":"publisher","first-page":"2002518","DOI":"10.1002\/advs.202002518","volume":"7","author":"Y Gao","year":"2020","unstructured":"Gao Y, Li X, Zeng C, Liu C, Hao Q, Li W, et al. CD63(+) Cancer-Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR-22. Adv Sci (Weinh). 2020;7(21):2002518.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1463_CR135","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41420-021-00506-z","volume":"7","author":"Y Zhan","year":"2021","unstructured":"Zhan Y, Du J, Min Z, Ma L, Zhang W, Zhu W, et al. Carcinoma-associated fibroblasts derived exosomes modulate breast cancer cell stemness through exonic circHIF1A by miR-580-5p in hypoxic stress. Cell Death Discov. 2021;7(1):141.","journal-title":"Cell Death Discov"},{"key":"1463_CR136","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.canlet.2019.10.039","volume":"469","author":"JE Kim","year":"2020","unstructured":"Kim JE, Kim BG, Jang Y, Kang S, Lee JH, Cho NH. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer. Cancer Lett. 2020;469:256\u201365.","journal-title":"Cancer Lett"},{"issue":"14","key":"1463_CR137","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.25541","volume":"8","author":"J Ren","year":"2018","unstructured":"Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932\u201348.","journal-title":"Theranostics."},{"issue":"1","key":"1463_CR138","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12967-020-02648-7","volume":"19","author":"L Zhou","year":"2021","unstructured":"Zhou L, Li J, Tang Y, Yang M. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p\/ANXA2 axis. J Transl Med. 2021;19(1):8.","journal-title":"J Transl Med"},{"key":"1463_CR139","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.omtn.2020.11.003","volume":"24","author":"X Chen","year":"2021","unstructured":"Chen X, Liu Y, Zhang Q, Liu B, Cheng Y, Zhang Y, et al. Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer. Mol Ther Nucleic Acids. 2021;24:113\u201326.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"3","key":"1463_CR140","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbrc.2020.04.142","volume":"527","author":"C Gu","year":"2020","unstructured":"Gu C, Lu H, Qian Z. Matrine reduces the secretion of exosomal circSLC7A6 from cancer-associated fibroblast to inhibit tumorigenesis of colorectal cancer by regulating CXCR5. Biochem Biophys Res Commun. 2020;527(3):638\u201345.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1463_CR141","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12885-021-08669-9","volume":"21","author":"K Yang","year":"2021","unstructured":"Yang K, Zhang J, Bao C. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214\/PD-L1 axis. BMC Cancer. 2021;21(1):933.","journal-title":"BMC Cancer"},{"issue":"3","key":"1463_CR142","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1002\/jcp.27111","volume":"234","author":"BL Li","year":"2019","unstructured":"Li BL, Lu W, Qu JJ, Ye L, Du GQ, Wan XP. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis. J Cell Physiol. 2019;234(3):2943\u201353.","journal-title":"J Cell Physiol"},{"key":"1463_CR143","doi-asserted-by":"crossref","unstructured":"Zhang N, Wang Y, Liu H, Shen W. Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1alpha\/VEGFA axis. Exp Cell Res. 2020;394(2):112113.","DOI":"10.1016\/j.yexcr.2020.112113"},{"issue":"3","key":"1463_CR144","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/CBM-160575","volume":"16","author":"N Nouraee","year":"2016","unstructured":"Nouraee N, Khazaei S, Vasei M, Razavipour SF, Sadeghizadeh M, Mowla SJ. MicroRNAs contribution in tumor microenvironment of esophageal cancer. Cancer Biomark. 2016;16(3):367\u201376.","journal-title":"Cancer Biomark"},{"issue":"7","key":"1463_CR145","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/cam4.2873","volume":"9","author":"G Zhao","year":"2020","unstructured":"Zhao G, Li H, Guo Q, Zhou A, Wang X, Li P, et al. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Cancer Med. 2020;9(7):2500\u201313.","journal-title":"Cancer Med"},{"issue":"1","key":"1463_CR146","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"key":"1463_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.676319","volume":"9","author":"H Shi","year":"2021","unstructured":"Shi H, Huang S, Qin M, Xue X, Guo X, Jiang L, et al. Exosomal circ_0088300 Derived From Cancer-Associated Fibroblasts Acts as a miR-1305 Sponge and Promotes Gastric Carcinoma Cell Tumorigenesis. Front Cell Dev Biol. 2021;9:676319.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1463_CR148","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-019-1144-9","volume":"38","author":"X Wang","year":"2019","unstructured":"Wang X, Qin X, Yan M, Shi J, Xu Q, Li Z, et al. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression. J Exp Clin Cancer Res. 2019;38(1):151.","journal-title":"J Exp Clin Cancer Res"},{"key":"1463_CR149","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.03.004","volume":"397","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li X, Sun W, Yue S, Yang J, Li J, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33\u201342.","journal-title":"Cancer Lett"},{"issue":"8","key":"1463_CR150","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/qjmed\/hcz093","volume":"112","author":"J You","year":"2019","unstructured":"You J, Li M, Cao LM, Gu QH, Deng PB, Tan Y, et al. Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes. QJM. 2019;112(8):581\u201390.","journal-title":"QJM."},{"key":"1463_CR151","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","volume":"36","author":"YY Li","year":"2018","unstructured":"Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018;36:209\u201320.","journal-title":"EBioMedicine."},{"issue":"4","key":"1463_CR152","first-page":"1319","volume":"42","author":"LP Sun","year":"2019","unstructured":"Sun LP, Xu K, Cui J, Yuan DY, Zou B, Li J, et al. Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma. Oncol Rep. 2019;42(4):1319\u201328.","journal-title":"Oncol Rep"},{"key":"1463_CR153","doi-asserted-by":"crossref","unstructured":"Chen JH, Wu ATH, Bamodu OA, Yadav VK, Chao TY, Tzeng YM, et al. Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21\/STAT3\/beta-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts. Cancers (Basel). 2019;12(1):56.","DOI":"10.3390\/cancers12010056"},{"issue":"6","key":"1463_CR154","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1021\/acs.jproteome.7b00925","volume":"17","author":"S Principe","year":"2018","unstructured":"Principe S, Mejia-Guerrero S, Ignatchenko V, Sinha A, Ignatchenko A, Shi W, et al. Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma. J Proteome Res. 2018;17(6):2045\u201359.","journal-title":"J Proteome Res"},{"issue":"9","key":"1463_CR155","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3727\/096504018X15336368805108","volume":"27","author":"JW Wang","year":"2019","unstructured":"Wang JW, Wu XF, Gu XJ, Jiang XH. Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI. Oncol Res. 2019;27(9):979\u201386.","journal-title":"Oncol Res"},{"key":"1463_CR156","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12935-019-1051-3","volume":"19","author":"H Guo","year":"2019","unstructured":"Guo H, Ha C, Dong H, Yang Z, Ma Y, Ding Y. Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A. Cancer Cell Int. 2019;19:347.","journal-title":"Cancer Cell Int"},{"issue":"56","key":"1463_CR157","doi-asserted-by":"publisher","first-page":"96035","DOI":"10.18632\/oncotarget.21635","volume":"8","author":"W Li","year":"2017","unstructured":"Li W, Zhang X, Wang J, Li M, Cao C, Tan J, et al. TGFbeta1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells. Oncotarget. 2017;8(56):96035\u201347.","journal-title":"Oncotarget."},{"issue":"11","key":"1463_CR158","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s12276-020-0431-z","volume":"52","author":"G Shan","year":"2020","unstructured":"Shan G, Gu J, Zhou D, Li L, Cheng W, Wang Y, et al. Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-beta signaling pathway. Exp Mol Med. 2020;52(11):1809\u201322.","journal-title":"Exp Mol Med"},{"issue":"9","key":"1463_CR159","first-page":"553","volume":"18","author":"E Lee","year":"2016","unstructured":"Lee E, Wang J, Yumoto K, Jung Y, Cackowski FC, Decker AM, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells. Which Promotes Prostate Cancer Metastasis Neoplasia. 2016;18(9):553\u201366.","journal-title":"Which Promotes Prostate Cancer Metastasis Neoplasia"},{"issue":"1","key":"1463_CR160","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ygyno.2015.04.015","volume":"138","author":"A Miyasaka","year":"2015","unstructured":"Miyasaka A, Oda K, Ikeda Y, Sone K, Fukuda T, Inaba K, et al. PI3K\/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-alpha\/VEGF pathway in endometrial cancer. Gynecol Oncol. 2015;138(1):174\u201380.","journal-title":"Gynecol Oncol"},{"key":"1463_CR161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4614-0899-4_2","volume":"727","author":"AJ Groot","year":"2012","unstructured":"Groot AJ, Vooijs MA. The role of Adams in Notch signaling. Adv Exp Med Biol. 2012;727:15\u201336.","journal-title":"Adv Exp Med Biol"},{"key":"1463_CR162","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250.","journal-title":"Elife."},{"issue":"1","key":"1463_CR163","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14789450.2020.1713103","volume":"17","author":"DI Cantor","year":"2020","unstructured":"Cantor DI, Cheruku HR, Westacott J, Shin JS, Mohamedali A, Ahn SB. Proteomic investigations into resistance in colorectal cancer. Expert Rev Proteomics. 2020;17(1):49\u201365.","journal-title":"Expert Rev Proteomics"},{"issue":"7","key":"1463_CR164","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.trecan.2016.05.010","volume":"2","author":"JJ Lin","year":"2016","unstructured":"Lin JJ, Shaw AT. Resisting Resistance: Targeted Therapies in Lung Cancer. Trends Cancer. 2016;2(7):350\u201364.","journal-title":"Trends Cancer."},{"key":"1463_CR165","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejmech.2017.11.056","volume":"143","author":"AI Shagufta","year":"2018","unstructured":"Shagufta AI. Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. Eur J Med Chem. 2018;143:515\u201331.","journal-title":"Eur J Med Chem"},{"key":"1463_CR166","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2018.04.009","volume":"41","author":"JN Mills","year":"2018","unstructured":"Mills JN, Rutkovsky AC, Giordano A. Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen\/aromatase inhibitors. Curr Opin Pharmacol. 2018;41:59\u201365.","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"1463_CR167","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000453133","volume":"11","author":"MP Lux","year":"2016","unstructured":"Lux MP, Fasching PA, Schrauder MG, Hein A, Jud SM, Rauh C, et al. The PI3K Pathway: Background and Treatment Approaches. Breast Care (Basel). 2016;11(6):398\u2013404.","journal-title":"Breast Care (Basel)"},{"issue":"4","key":"1463_CR168","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3892\/or.2014.3047","volume":"31","author":"G Wang","year":"2014","unstructured":"Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, Li X, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt\/beta-catenin signaling pathway. Oncol Rep. 2014;31(4):1839\u201345.","journal-title":"Oncol Rep"},{"issue":"3","key":"1463_CR169","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019;49(3):347\u201360.","journal-title":"Dev Cell"},{"issue":"4","key":"1463_CR170","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1463_CR171","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/imr.12657","volume":"283","author":"JL Reading","year":"2018","unstructured":"Reading JL, Galvez-Cancino F, Swanton C, Lladser A, Peggs KS, Quezada SA. The function and dysfunction of memory CD8(+) T cells in tumor immunity. Immunol Rev. 2018;283(1):194\u2013212.","journal-title":"Immunol Rev"},{"issue":"9","key":"1463_CR172","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015;125(9):3384\u201391.","journal-title":"J Clin Invest"},{"issue":"7718","key":"1463_CR173","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382\u20136.","journal-title":"Nature."},{"key":"1463_CR174","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3389\/fimmu.2020.02026","volume":"11","author":"D Dou","year":"2020","unstructured":"Dou D, Ren X, Han M, Xu X, Ge X, Gu Y, et al. Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92\/PD-L1 Pathway. Front Immunol. 2020;11:2026.","journal-title":"Front Immunol"},{"issue":"4","key":"1463_CR175","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168(4):613\u201328.","journal-title":"Cell."},{"issue":"3","key":"1463_CR176","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.celrep.2019.01.009","volume":"27","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Higginbotham JN, Jeppesen DK, Yang YP, Li W, McKinley ET, et al. Transfer of Functional Cargo in Exomeres. Cell Rep. 2019;27(3):940\u201354.","journal-title":"Cell Rep"},{"key":"1463_CR177","doi-asserted-by":"crossref","unstructured":"Yin Z, Yu M, Ma T, Zhang C, Huang S, Karimzadeh MR, et al. Mechanisms underlying low-clinical responses to PD-1\/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. J Immunother Cancer. 2021;9(1):e001698.","DOI":"10.1136\/jitc-2020-001698"},{"issue":"7","key":"1463_CR178","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","volume":"6","author":"SM Morrissey","year":"2020","unstructured":"Morrissey SM, Yan J. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy. Trends Cancer. 2020;6(7):550\u20138.","journal-title":"Trends Cancer."},{"issue":"5","key":"1463_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101047","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, Zeng H, Zhang H, Han Y. The role of exosomal PD-L1 in tumor immunotherapy. Transl Oncol. 2021;14(5):101047.","journal-title":"Transl Oncol"},{"issue":"8","key":"1463_CR180","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Li CW, Chan LC, Wei Y, Hsu JM, Xia W, et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018;28(8):862\u20134.","journal-title":"Cell Res"},{"issue":"16","key":"1463_CR181","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1073\/pnas.1203479109","volume":"109","author":"P Yu","year":"2012","unstructured":"Yu P, Steel JC, Zhang M, Morris JC, Waitz R, Fasso M, et al. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Proc Natl Acad Sci U S A. 2012;109(16):6187\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1463_CR182","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ymthe.2016.10.009","volume":"25","author":"N Nishida-Aoki","year":"2017","unstructured":"Nishida-Aoki N, Tominaga N, Takeshita F, Sonoda H, Yoshioka Y, Ochiya T. Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis. Mol Ther. 2017;25(1):181\u201391.","journal-title":"Mol Ther"},{"issue":"1","key":"1463_CR183","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","volume":"8","author":"A Datta","year":"2018","unstructured":"Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, et al. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer. Sci Rep. 2018;8(1):8161.","journal-title":"Sci Rep"},{"key":"1463_CR184","doi-asserted-by":"publisher","first-page":"8839978","DOI":"10.1155\/2021\/8839978","volume":"2021","author":"S Ayala-Mar","year":"2021","unstructured":"Ayala-Mar S, Donoso-Quezada J, Gonzalez-Valdez J. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy. J Immunol Res. 2021;2021:8839978.","journal-title":"J Immunol Res"},{"issue":"6","key":"1463_CR185","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754\u201363.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"1463_CR186","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1039\/D0NR07622H","volume":"13","author":"L Duan","year":"2021","unstructured":"Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, et al. Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale. 2021;13(3):1387\u201397.","journal-title":"Nanoscale."},{"issue":"1","key":"1463_CR187","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 2019;10(1):3838.","journal-title":"Nat Commun"},{"key":"1463_CR188","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biomaterials.2017.01.004","volume":"121","author":"E Koh","year":"2017","unstructured":"Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, et al. Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 2017;121:121\u20139.","journal-title":"Biomaterials."},{"issue":"5","key":"1463_CR189","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/anie.201912524","volume":"59","author":"W Nie","year":"2020","unstructured":"Nie W, Wu G, Zhang J, Huang LL, Ding J, Jiang A, et al. Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy. Angew Chem Int Ed Engl. 2020;59(5):2018\u201322.","journal-title":"Angew Chem Int Ed Engl."},{"key":"1463_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120964","volume":"275","author":"LL Cheng","year":"2021","unstructured":"Cheng LL, Zhang XZ, Tang JJ, Lv QJ, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy. Biomaterials. 2021;275:120964.","journal-title":"Biomaterials."},{"key":"1463_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110237","volume":"128","author":"X Zhao","year":"2020","unstructured":"Zhao X, Wu D, Ma X, Wang J, Hou W, Zhang W. Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake. Biomed Pharmacother. 2020;128:110237.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1463_CR192","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/mt.2014.202","volume":"23","author":"SF Ahmed","year":"2015","unstructured":"Ahmed SF, Das N, Sarkar M, Chatterjee U, Chatterjee S, Ghosh MK. Exosome-mediated delivery of the intrinsic C-terminus domain of PTEN protects it from proteasomal degradation and ablates tumorigenesis. Mol Ther. 2015;23(2):255\u201369.","journal-title":"Mol Ther"},{"issue":"243","key":"1463_CR193","doi-asserted-by":"publisher","first-page":"ra70","DOI":"10.1126\/scisignal.2003084","volume":"5","author":"U Putz","year":"2012","unstructured":"Putz U, Howitt J, Doan A, Goh CP, Low LH, Silke J, et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal. 2012;5(243):ra70.","journal-title":"Sci Signal"},{"issue":"2","key":"1463_CR194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1074\/mcp.M112.022806","volume":"12","author":"M Demory Beckler","year":"2013","unstructured":"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics. 2013;12(2):343\u201355.","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"1463_CR195","first-page":"2432","volume":"8","author":"LR Languino","year":"2016","unstructured":"Languino LR, Singh A, Prisco M, Inman GJ, Luginbuhl A, Curry JM, et al. Exosome-mediated transfer from the tumor microenvironment increases TGF\u03b2 signaling in squamous cell carcinoma. Am J Transl Res. 2016;8(5):2432\u20137.","journal-title":"Am J Transl Res"},{"key":"1463_CR196","doi-asserted-by":"crossref","unstructured":"De Jaeghere EA, DH, De Wever O. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment. Trends Cancer. 2019;5(11):704\u201323.","DOI":"10.1016\/j.trecan.2019.09.009"},{"issue":"1","key":"1463_CR197","doi-asserted-by":"publisher","first-page":"1785161","DOI":"10.1080\/20013078.2020.1785161","volume":"9","author":"K Popowski","year":"2020","unstructured":"Popowski K, Lutz H, Hu S, George A, Dinh PU, Cheng K. Exosome therapeutics for lung regenerative medicine. J Extracell Vesicles. 2020;9(1):1785161.","journal-title":"J Extracell Vesicles"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-021-01463-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T22:16:31Z","timestamp":1675980991000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01463-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":197,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1186\/s12943-021-01463-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"1 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}